Stem cells reside in niches that have much lower oxygen concentration than many other parts of the body. Hypoxia maintains the niche where stem cells stay in optimal condition that benefits the self-renewal capacities of human embryonic, mesenchymal, hematopoietic and neural stem cells.
SFRR-Europe congratulate Sir Peter Ratcliffe, recipient of the SFRR-Europe Annual Award at the SFFR-International meeting held in Lisboa in 2018, on the 2019 Nobel Prize in Physiology and Medicine. Sir Peter shares the award with Gregg Semenza (SFRBM 2017 discovery award recipient) and William Kaelin, for their work on decoding how cells sense and respond to oxygen levels. Learn More.
The celebrations continue as users get up close with the InvivO2 Physiological Workstation, used for hypoxia research by one of the recent Noble Prize recipients in Physiology or Medicine, Sir Peter J. Ratcliffe.
Director of Scientific Applications, Krista Rantanen Ph.D. presented “Physiological Oxygen in Life Science Research
Kara Held, Ph.D., Baker's science director, presented her findings from the latest instalment of "BSC MythBusters, Can 2+ people Work in a BSC Safely?
Metal fingerprinting in coronary heart disease for better diagnosis and treatment using a special oxygen-controlled workstation from Baker Ruskinn!
William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza have been joinly awarded The Nobel Prize in Physiology or Medicine 2019 "for their discoveries of how cells sense and adapt to oxygen availability." Announced Monday October 7 at 11.30 GMT.
The 5th in our series of workshops - a day for those interested in Physiological Normoxia for Cell Culture.
Sign up to our monthly newsletter to stay up to date on everything that’s going on at Baker.